Form4insider filings, from the source

SEC Form 4 · accession 0001232524-18-000048

Jazz Pharmaceuticals plc · JAZZ

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Paul Treacy
Officer — SVP, Technical Operations
Period of report
Mar 1, 2018
Accepted (ET)
Mar 5, 2018 · 4:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary SharesF2Mar 1, 2018A3,600$0.00A20,112D
Ordinary SharesMar 2, 2018S525$139.6155D19,587D
Ordinary SharesMar 2, 2018S352$139.6258D19,235D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Non-Qualified Stock Option (right to buy)F4$140.67Mar 1, 2018A9,000A—Feb 29, 2028Ordinary Shares9,0009,000D

Explanation of responses